SCHEMBL8106097

SCHEMBL8106097

CS(=O)(=O)Cc1cc(N)nc(-c2ccc(NC(=O)CCC(F)(F)F)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 6/20 0.46
MTOR P42345 4/20 0.46
PIK3CD O00329 6/20 0.45
RORC P51449 1/20 0.41
MAPT P10636 4/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 2/20 0.39
NAMPT P43490 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
TP53 P04637 2/20 0.37
RXFP1 Q9HBX9 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8103980 0.90 PIK3CA (0.47) PIK3CAMTORPIK3CDMAPTKDM4E
SCHEMBL8101525 0.88 TP53 (0.51) PIK3CAMTORPIK3CDMAPTKDM4E
SCHEMBL8099598 0.86 PIK3CD (0.45) PIK3CAMTORPIK3CDMAPTKDM4E
SCHEMBL8093349 0.85 PIK3CD (0.48) PIK3CAMTORPIK3CDMAPTKDM4E
SCHEMBL8101524 0.85 MEN1 (0.54) PIK3CAMTORPIK3CDMAPTKDM4E
SCHEMBL8098207 0.85 PIK3CD (0.48) PIK3CAMTORPIK3CDMAPTMEN1
SCHEMBL8109730 0.85 PIK3CD (0.45) PIK3CAMTORPIK3CDMAPTKDM4E
SCHEMBL8095869 0.84 PIK3CA (0.46) PIK3CAMTORPIK3CDMAPTKDM4E
SCHEMBL8106107 0.84 CA12 (0.49) PIK3CAMTORPIK3CDMAPTKDM4E
SCHEMBL8109734 0.83 PIK3CD (0.45) PIK3CAMTORPIK3CDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007749-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed